Expertise in
8
conditions

Andreas Schwarting

Kaiser Wilhelm Str. 9-11, 
Bad Kreuznach, RP, DE 
Expertise in
8
conditions
Kaiser Wilhelm Str. 9-11, 
Bad Kreuznach, RP, DE 

Overview

Andreas Schwarting practices practicing medicine in Bad Kreuznach, Germany.

Mr. Schwarting is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Antisynthetase Syndrome, Systemic Lupus Erythematosus (SLE), Arthritis, and Myositis.

He is actively involved in clinical research, co-authoring 143 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

Kaiser Wilhelm Str. 9-11, Bad Kreuznach, RP 55543, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A 5-Year Prospective Observational Registry to Assess Adverse Events of Interest and Effectiveness in Adults With Active, Autoantibody-Positive Systemic Lupus Erythematosus Treated With or Without BENLYSTA™ (Belimumab)
A 5-Year Prospective Observational Registry to Assess Adverse Events of Interest and Effectiveness in Adults With Active, Autoantibody-Positive Systemic Lupus Erythematosus Treated With or Without BENLYSTA™ (Belimumab)
Enrollment Status: Completed
Publish Date: March 20, 2026
Intervention Type: Other, Biological
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
Enrollment Status: Terminated
Publish Date: May 16, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 3 Study of Baricitinib in Patients With Systemic Lupus Erythematosus
Enrollment Status: Terminated
Publish Date: January 30, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
View 2 Less Clinical Trials

143 Total Publications

Optical Spectral Transmission Imaging in Patients with Osteoarthritis: A Comparative Study with Joint Ultrasound and Clinical Markers.
Optical Spectral Transmission Imaging in Patients with Osteoarthritis: A Comparative Study with Joint Ultrasound and Clinical Markers.
Journal: Rheumatology and therapy
Published: April 10, 2026

Frequently Asked Questions about Andreas Schwarting

Is Andreas Schwarting a top-rated expert for Antisynthetase Syndrome?

MediFind is an objective health platform that identifies experts based on real-world data. Andreas Schwarting is classified as an Elite expert for Antisynthetase Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Andreas Schwarting participate in research or clinical trials?

Yes. Andreas Schwarting has published 143 articles and abstracts on conditions like Antisynthetase Syndrome. You can view a list of Andreas Schwarting's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Schwarting's expertise for a condition
ConditionClose
View All 40 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile